Letter to the editor: Lymphangiogenesis in primary breast cancer.
Van den Eynden
Gert G
GG
Van der Auwera
Ilse
I
Colpaert
Cecile G
CG
Dirix
Luc Y
LY
Van Marck
Eric A
EA
Vermeulen
Peter B
PB
D018952:Antigens, CD34 / Q000032:analysis; D001943:Breast Neoplasms / Q000737:chemistry / Q000473:pathology / Q000503:physiopathology*; D018270:Carcinoma, Ductal, Breast / Q000737:chemistry / Q000473:pathology / Q000503:physiopathology*; D049109:Cell Proliferation; D042783:Endothelial Cells / Q000473:pathology; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D019394:Ki-67 Antigen / Q000032:analysis; D042583:Lymphangiogenesis; D042601:Lymphatic Vessels / Q000737:chemistry / Q000473:pathology / Q000503:physiopathology*; D008562:Membrane Glycoproteins / Q000032:analysis; D000098853:Podoplanin
D018952:Antigens, CD34; D019394:Ki-67 Antigen; D008562:Membrane Glycoproteins; C117468:PDPN protein, human; D000098853:Podoplanin